临床医师对第一发抑郁症患者药物疗法的有效性:基于药物基因组的随机对照试验
1Clinical Research Center for Mental Disorders, Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University, Shanghai, China.
Frontiers in pharmacology
|August 25, 2025
概括
在抑郁症患者中,以药物遗传学为指导的治疗减少了无情感和副作用. 精神病学家的经验影响了抗抑郁药的变化,更有经验的医生做出更少的调整,
科学领域:
- 精神病学
- 药物基因组学
- 临床医学
背景情况:
- 选择抗抑郁药因有效性,副作用和患者个性的不同而具有挑战性.
- 没有先前的研究使用药物基因组学方法比较不同经验水平的精神病学家之间的抗抑郁药物治疗疗效.
研究的目的:
- 将药物基因组指导抗抑郁药治疗与标准治疗的疗效进行比较.
- 研究精神病学家对治疗结果的影响.
- 评估药物基因组学对抑郁症状,无情感和副作用的影响.
主要方法:
- 178名患有第一次抑郁症的患者随机分为药物基因组指导或常规治疗组.
- 在基线进行了药物基因组评估.
- 汉密尔顿抑郁量表 (HAM- D17),维度无情评分量表 (DARS),PDQ- D和ASEC在整个32周内进行.
主要成果:
- 与对照组相比,药物遗传学组在32周后的DARS和ASEC得分显著改善.
- 其他医生对抗抑郁药物做出更大改变.
- 较高的临床经验与抗抑郁药物变化数量和HAM- D17得分有负相关性.
结论:
- 药物基因组学指导的治疗有效地减少了第一次抑郁的无情感和副作用.
- 增加精神病医生的经验导致抗抑郁药变化较少和更好的症状控制.
- 药物基因组学可以将临床经验对抑郁症治疗结果的影响降到最低.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:25Antidepressant Drugs: Overview
750
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
750
01:28Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
568
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
568
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K